OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Yao Liu, Lili Niu, Nannan Li, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 64

Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors
Keshuang Zheng, Yongpu Feng, Lie Li, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 761-787
Open Access | Times Cited: 17

Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13

Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Min Yang, Peiluan Zhong, Pengcheng Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2056-2056
Open Access | Times Cited: 1

Neutrophil hitchhiking nanoparticles enhance bacteria-mediated cancer therapy via NETosis reprogramming
Yuzhen Zhao, Mingge Li, Yue Guo, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 661-675
Closed Access | Times Cited: 7

Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 7

Studying the Oncolytic Activity of Streptococcus pyogenes Strains Against Hepatoma, Glioma, and Pancreatic Cancer In Vitro and In Vivo
Anna Tsapieva, Alexander N. Chernov, N. V. Duplik, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 76-76
Open Access

Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy
Gabriela Christina Kuhl, Mark Tangney
Cancers (2025) Vol. 17, Iss. 5, pp. 723-723
Open Access

Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics
Wenxin Chen, Qiyan Guo, Hong Li, et al.
Advanced Science (2025)
Open Access

The potential use of bacteria and their derivatives as delivery systems for nanoparticles in the treatment of cancer
Shiva Ahmadishoar, Saba Saeed, Morug Salih Mahdi, et al.
Journal of drug targeting (2025), pp. 1-54
Closed Access

Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination
Yanchao Zhang, Tom S. Bailey, Philip Hittmeyer, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4

A biomimetic spore nanoplatform for boosting chemodynamic therapy and bacteria-mediated antitumor immunity for synergistic cancer treatment
Cuixia Zheng, Lingling Sun, Hongjuan Zhao, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100912-100912
Open Access | Times Cited: 4

Microbe-material hybrids for therapeutic applications
Meng Chen, Lili Xia, Chenyao Wu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 16, pp. 8306-8378
Closed Access | Times Cited: 4

Applications of Nanomaterial‐Microorganism Hybrid Systems in the Treatment of Tumor
Muhammad Shamim Khan, Mirza Albash Baig, Tian Meng, et al.
Advanced Therapeutics (2025)
Closed Access

Deprivation of methionine inhibits osteosarcoma growth and metastasis via C1orf112-mediated regulation of mitochondrial functions
Xindan Zhang, Zhenggang Zhao, Xuepeng Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 3

Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives
Jinling Liu, Chongsheng He, Wenzhi Tan, et al.
Life Sciences (2024) Vol. 352, pp. 122897-122897
Closed Access | Times Cited: 3

Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy
Fatemeh Moradbeygi, Younes Ghasemi, Ahmad Reza Farmani, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115292-115292
Open Access | Times Cited: 7

Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7

Harnessing and Mimicking Bacterial Features to Combat Cancer: From Living Entities to Artificial Mimicking Systems
Peng Gao, Zhenyu Duan, Gang Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 2

Bacterial therapy: a promising strategy for cancer immunotherapy
Yinsong Wang
Cancer Biology and Medicine (2023), pp. 1-4
Open Access | Times Cited: 5

Coated Bacteria: Advanced Living Materials for Microbial Therapy
Zhenping Cao, Jinyao Liu
Accounts of Materials Research (2024) Vol. 5, Iss. 7, pp. 872-883
Open Access | Times Cited: 1

Advances in nanotechnology-based approaches for the treatment of head and neck squamous cell carcinoma
Bicai Tang, Rui Huang, MA Wen-juan
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38668-38688
Open Access | Times Cited: 1

Application of Invasive Bacteria for the Delivery of Anti-Cancer Therapeutics
Rasaq Akinsola, Kumaran Narayanan
Therapeutics (2024) Vol. 1, Iss. 2, pp. 124-141
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top